Domov › Rakovina vaječníkov › Minnesota › Minneapolis
Klinické štúdie Rakovina vaječníkov v meste Minneapolis, MN
24 štúdií pre Rakovina vaječníkov hľadá účastníkov v zariadeniach v meste Minneapolis a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Minneapolis VA Medical Center, Minneapolis
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Prebieha náborFáza 3
- Masonic Cancer Center, University of Minnesota, Minneapolis
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Prebieha náborFáza 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 míľ odtiaľ
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 míľ odtiaľ
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Prebieha náborFáza 2
- University Of Minnesota /ID# 277850, Minneapolis
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Prebieha náborFáza 2
- University of Minnesota - Minneapolis /ID# 275718, Minneapolis
- Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 274780, Saint Louis Park · 5 míľ odtiaľ
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Prebieha náborFáza 2
- Minnesota Oncology-Minneapolis, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Prebieha náborFáza 1
- University of Minnesota, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Prebieha náborFáza 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Prebieha náborFáza 1
- Normunity Investigational Site, Minneapolis
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Prebieha nábor
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- a 2 ďalších
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Prebieha náborFáza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- a 2 ďalších
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Prebieha náborFáza 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Prebieha náborFáza 2
- 518, Minneapolis
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Prebieha náborFáza 2
- University of Minnesota - Masonic Cancer Center, Minneapolis
UNTOLD Ovarian Cancer Unmet Needs Survey
Prebieha náborObservačná štúdia
- Masonic Cancer Center, Minneapolis
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Prebieha náborFáza 1
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Prebieha náborFáza 3
- Minnesota Oncology Hematology PA, Minneapolis
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
Prebieha náborVítaní zdravých dobrovoľníkov
- University of Minnesota, Minneapolis
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Prebieha náborFáza 1
- University of Minnesota, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Allina Health Cancer Institute, Minneapolis
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Prebieha náborFáza 2
- SCRI - Minnesota Oncology Hematology, P.A., Minneapolis
- University of Minnesota, Minneapolis
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
Prebieha náborFáza 1
- University of Minnesota, Minneapolis
Štúdie Rakovina vaječníkov v iných mestách
- Houston, TX89 štúdií
- New York City, NY69 štúdií
- Boston, MA61 štúdií
- Los Angeles, CA50 štúdií
- Nashville, TN49 štúdií
- Arlington, VA46 štúdií
- Philadelphia, PA44 štúdií
- Columbus, OH39 štúdií
- St. Louis, MO38 štúdií
- Chicago, IL36 štúdií
- San Antonio, TX31 štúdií
- Cleveland, OH30 štúdií
Iné štúdie v Minneapolis
- Nemalobunkový karcinóm pľúc27 štúdií
- Rakovina prsníka27 štúdií
- Rakovina prostaty23 štúdií
- Rakovina (všetky typy)22 štúdií
- Srdcové zlyhanie21 štúdií
- Akútna myeloidná leukémia20 štúdií
- Rakovina pľúc20 štúdií
- Kolorektálny karcinóm19 štúdií
- Rakovina endometria18 štúdií
- Parkinsonova choroba17 štúdií
- Kardiovaskulárne ochorenia15 štúdií
- Koronárne ochorenie srdca13 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.